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Abstract
It has been suggested that receptor-ligand complexes segregate or co-localise within immune synapses according to their
size, and this is important for receptor signaling. Here, we set out to test the importance of receptor-ligand complex
dimensions for immune surveillance of target cells by human Natural Killer (NK) cells. NK cell activation is regulated by
integrating signals from activating receptors, such as NKG2D, and inhibitory receptors, such as KIR2DL1. Elongating the
NKG2D ligand MICA reduced its ability to trigger NK cell activation. Conversely, elongation of KIR2DL1 ligand HLA-C reduced
its ability to inhibit NK cells. Whereas normal-sized HLA-C was most effective at inhibiting activation by normal-length MICA,
only elongated HLA-C could inhibit activation by elongated MICA. Moreover, HLA-C and MICA that were matched in size co-
localised, whereas HLA-C and MICA that were different in size were segregated. These results demonstrate that receptor-
ligand dimensions are important in NK cell recognition, and suggest that optimal integration of activating and inhibitory
receptor signals requires the receptor-ligand complexes to have similar dimensions.
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Introduction
NK cell activation is regulated by a balance of signals from
various germ-line encoded activating receptors and inhibitory
receptors [1,2]. One of the best studied activating receptors is the
lectin-like receptor NKG2D, which recognises proteins that are
usually not expressed on cells but are upregulated in response to
cellular stress [3,4,5,6]. Signaling downstream from activating
receptors commonly involves the phosphorylation of the immu-
noreceptor-tyrosine based activation motifs (ITAMs). NKG2D
signals via an adapter DAP10 that contains an ITAM-like motif
(YXNM), which can be phosphorylated by Src-family kinases [7].
Human inhibitory NK cell receptors include members of the
Killer-cell Immunoglobulin-like Receptor (KIR) and the Leuko-
cyte Ig-like receptor (LILR) families, and the CD94:NKG2A
heterodimer, all of which recognise class I MHC molecules.
Ligation of KIR2DL1 by a subset of class I MHC proteins that
includes HLA-Cw4 and -Cw6 inhibits NK cell-mediated lysis [8].
In this manner, loss of class I MHC protein from the surface,
i.e. ‘‘missing self’’, can render cells susceptible to NK lysis
[9,10,11,12]. KIR2DL1 signal transduction is mediated via
immunoreceptor-tyrosine based inhibition motifs (ITIMs) which
are phosphorylated by tyrosine kinases and then recruit SH2-
domain containing phosphatases [13,14].
Lymphocyte activation involves the engagement of multiple cell
surface receptors with ligands presented on the surface of other
cells in a contact area termed the immunological or immune
synapse (IS) [15,16,17,18,19,20]. Because lymphocyte cell surface
molecules vary considerably in size it has been suggested that they
may segregate according to size within the IS [21]. This hypothesis
specifically suggests that receptor-ligand complexes with similar
dimensions would be expected to co-localise, whereas those
differing in size would be expected to segregate. Lymphocyte
signaling is initiated by tyrosine phosphorylation, which is
regulated by the balance between tyrosine kinases and phospha-
tases at the cell membrane. The kinetic-segregation model of T cell
antigen recognition proposed that signaling is initiated by size-
based segregation of the engaged T cell receptor (TCR) from
receptor tyrosine phosphatases with large ectodomains such as
CD45 and CD148, leading to phosphorylation of the TCR/CD3
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complex [22]. A number of studies have provided support for this
model [23]. Firstly, molecules at the T cell IS do segregate
according to size [15,16,24], although active, cytoskeletally-driven
transport processes are also involved [25]. Secondly, CD45 and
CD148 are excluded from the site of TCR engagement and
triggering [26,27]. Thirdly, truncation of CD45 and CD148
ectodomains [28,29] and elongation of TCR ligands [30,31]
abrogate TCR triggering.
However, whereas T cell activation is controlled primarily by a
single receptor, i.e. the TCR, NK cells are regulated by the
integration of signals from a number of activating and inhibitory
receptors [32]. Thus, it is not immediately obvious how the
dimensions of protein complexes would influence signal integration
by multiple receptors expressed by NK cells. Intriguingly, both the
inhibitory HLA/KIR and activating NKG2D/MICA complexes
are small, spanning 10–15 nm [33,34,35], and have been shown to
segregate within the IS from the larger [,40 nm [21,36]] integrin/
ligand complex LFA1/ICAM-1, even in the absence of any active
or cytoskeletally-driven process [17,19,37,38].
Here we explore the role of ectodomain size in NK cell
activation by manipulating the length of activating and/or
inhibitory receptor ligands. Specifically, we analysed the effects
of elongating MICA and/or HLA-Cw6 on NK cell activation or
inhibition, and examine how size influences segregation within the
NK cell IS. We show that ligand elongation abrogates both
activating and inhibitory receptor function. We also demonstrate
that size compatibility is important for the colocalization of, and
signal integration between, engaged activating and inhibitory
receptors, and that differences in ectodomain size are sufficient to
drive segregation within the IS. This suggests a general principle
for the importance of proteins size in how signals integrate from
multiple receptor/ligand interactions across intercellular contacts.
Results
The size of MICA is important in triggering NKG2D-
dependent lysis
The size of MICA was varied by inserting 2, 3 or 4
independently-folding Ig domains from CD2, CD22, or CD4
respectively [30,31], in the stalk region linking the transmembrane
and extracellular domains (Figure 1A). These inserts were chosen
because they are structurally well-characterised and have previ-
ously been shown to elongate cell surface proteins without
disrupting their ligand binding properties [30,31]. These differ-
ently-sized variants of MICA were then expressed in the mouse
mastocytoma cell line P815, which does not express any ligand for
human NKG2D endogenously. Transfected P815 cells were
selected for comparable expression levels by fluorescence-activated
cell sorting (Figure 1A) and then tested for their susceptibility to
lysis by NK cells (Figure 1B). Expression of normal-length MICA
was sufficient to induce lysis of P815 cells by the immortal human
NK cell tumor line NKL. However, elongation of the MICA-
ectodomain significantly reduced its ability to trigger lysis. Indeed,
the ability of MICA to trigger NK cell cytotoxicity varied inversely
with its length.
To test whether elongation affected other functional responses,
we also compared the ability of normal-length and elongated
MICA to trigger IFN-c production by NKL cells. While normal-
length MICA was sufficient to trigger IFN-c, MICA elongated by
2 or 3 Ig domains was less stimulatory and MICA extended by
4 Ig domains did not elicit any IFN-c response (Figure 1C).
Similar results were obtained when we assayed intracellular IFN-c
production by flow cytometry, confirming that this effect was the
result of decreased IFN-c production rather than increased
consumption (Figure S1A). Elongation of MICA also abrogated
NK cell degranulation as measured by induction of CD107a
expression on the cell surface (Figure S1B). Finally, elongation of
MICA also inhibited target cell lysis and IFN-c production by
primary NK cells (Figure 1D, E).
In order to examine the effect of elongation of MICA on earlier
activation events we also examined the phosphorylation of SLP-
76, an adapter protein involved in the early stages of NKG2D
signaling [39]. Incubation of NKL cells with MICA-expressing
P815 cells induced SLP-76 phosphorylation within 2 min of co-
incubation. The extent of phosphorylation was dramatically
decreased by elongation of MICA (Figure 1F). Thus, elongation
of MICA abrogates the early stages of NKG2D signaling as well as
later cellular responses.
Elongated MICA proteins bind to NKG2D
To test the ability of elongated MICA to be bound by NKG2D,
we compared the binding of NKG2D-coated beads to P815 cells
expressing normal-length versus elongated forms of MICA
(Figure 2A). NKG2D-coated beads bound at similar levels to
P815 cells expressing normal-length or elongated MICA both in
the absence (Figure 2A) and presence (Figure S2) of a titrated
blocking antibody, indicating that the different length variants of
MICA had a comparable ability to bind NKG2D.
To examine whether elongated variants of MICA could bind
NKG2D in the context of an intercellular contact, we used flow
cytometry to measure conjugate formation between NKL cells and
P815 transfectants (Figure 2B). Expression of all MICA variants on
P815 cells resulted in a comparable increase in conjugate
formation, indicating that the elongated forms of MICA are able
to bind NKG2D in a cell-cell interface (Figure 2B).
As a final test of the ability of elongated MICA to bind NKG2D
we examined their clustering in IS between NKL and P815 cells
expressing variants of MICA tagged with GFP, using confocal
fluorescent microscopy. Normal-length MICA-GFP accumulated
at the IS, leading to a 6–8 fold increase in fluorescence intensity
compared to elsewhere at the cell surface (Figure 2C). MICA
elongated with 2 (MICA-CD2) or 4 (MICA-CD4) Ig domains
clustered at the IS to a similar extent (Figure 2C), providing
further confirmation that elongation of MICA does not abrogate
binding to NKG2D at the cell-cell interface.
Elongation of HLA-Cw6 reduces KIR2DL1-mediated
inhibition
Since the length of MICA was shown to be important for
NKG2D-dependent activation, we next examined whether
recognition by inhibitory receptors was also influenced by the size
of their ligands. For this we used the well-characterised cell line
YTS, which is activated principally via engagement of the 2B4 and
CD28 receptors [40,41] and does not endogenously express
inhibitory receptors for HLA-C. YTS cells transfected to express
the inhibitory receptor KIR2DL1 (YTS-KIR2DL1) can be
inhibited by expression on target cells of the KIR2DL1 ligand
HLA-Cw6 [42]. To allow us to vary the size of HLA-Cw6 without
confounding effects on peptide loading and HLA-Cw6 assembly
we expressed it as a single-chain trimer fusion protein (hereafter
termed Cw6) comprising a peptide, b2-microglobulin, and the
HLA-Cw6 heavy chain joined by flexible glycine/serine linkers
[43]. The size of Cw6 was varied, as with MICA, by inserting Ig
domains from CD2, CD22, or CD4 into the stalk region linking
the transmembrane and extracellular domains (Figure 3A).
Transfectants were selected to express these constructs at
comparable (high and low) levels on 721.221 cells (hereafter
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termed 221), EBV-transformed B cells which lack endogenous
class I MHC protein expression (Figure 3A) [44].
Expression of normal-length Cw6 on 221 cells strongly inhibited
killing by YTS/KIR2DL1 cells (Figure 3B). In contrast, elongated
forms of Cw6 were less effective inhibitors, with the extent of
inhibition progressively decreased with increasing Cw6 length
(Figure 3B). Similarly, whereas normal-length Cw6 strongly
inhibited IFN-c secretion, elongated forms of Cw6 were far less
inhibitory, even when expressed at high levels (Figure 3C). Similar
results were obtained when intracellular IFN-c was measured
(Figure S3).
Elongated Cw6 can bind to KIR2DL1
One possible explanation for elongated Cw6 being less effective
at inhibiting NK cell responses is that it could simply be unable to
bind KIR2DL1. To test for this, we compared the binding of
Figure 1. Elongation of MICA abrogates its ability to activate NK cells. (A) Normal-length and elongated forms of MICA-GFP were expressed
at comparable levels in P815 cells. MICA was elongated by inserting 2, 3 or 4 Ig domains from CD2, CD22, or CD4. (B-E) Effect of MICA elongation on
target cell lysis (B, D) and IFN-c production (C, E) by NKL (B, C) or IL-2 stimulated primary NK (D, E) cells. For lysis, NK cells were incubated with [35S]-
Met labeled P815 cells expressing normal-length or elongated MICA for 5 h at the indicated E:T ratios. Lysis percentages are expressed as [35S]-Met
release relative to total [35S]-Met. The data in B and D are representative results from three experiments. For IFN-c secretion, NK cells incubated for
16 h at the indicated E:T ratios (or E:T = 1:1 for panel E) with P815 cells expressing normal-length or elongated MICA. IFN-c secretion was quantified
by ELISA. Data in C and E are representative results from four and two experiments respectively. Error bars are SD of triplicate measurements. In all
panels B-E the same key applies for each bar, as indicated in panel B. (F) Effect of MICA elongation on NKG2D signaling. NKL cells were stimulated by
P815 cells expressing normal-length and elongated MICA for 2 min. Cell lysates were analysed by Western-blot using an antibody specific for the
phospho-tyrosine 113 of SLP-76.
doi:10.1371/journal.pone.0015374.g001
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KIR2DL1-coated fluorescent beads to 221 cells expressing the
various forms of Cw6. KIR2DL1-coated beads bound at
comparable levels to cells expressing wild type and elongated
Cw6 both in the absence (Figure 4A) and presence (Figure S4) of a
titrated blocking antibody, indicating that elongation of Cw6 does
not disrupt its interaction with KIR2DL1.
We next examined whether elongated Cw6 could bind
KIR2DL1 in the context of an intercellular contact. To do
this we examined conjugate formation between KIR2DL1-
expressing NKL cells and P815 cells expressing normal-
length or elongated Cw6. Expression of normal-length Cw6
on P815 cells resulted in a substantial increase in conjugate
formation, with over 50% of NKL cells forming conjugates
(Figure 4B). A similar level of conjugate formation was seen with
Cw6-CD4, indicating effective binding of KIR2DL1 at the IS
(Figure 4B).
As a final test of whether elongation of Cw6 affected KIR2DL1
binding we used live-cell confocal microscopy to visualize the
accumulation of KIR2DL1-GFP and Cw6-mCherry at the
interface between YTS and 221 transfectants (Figure 4C). This
revealed that both normal-length and CD4-elongated Cw6
accumulated to similar extents and induced a similar level of
accumulation of KIR2DL1; KIR2DL1 was enriched 6.262.0 fold
(n = 14) at the IS with target cells expressing Cw6 and 5.061.5
fold (n = 13) for target cells expressing Cw6-CD4 (Figure 4C). The
fact that KIR enrichment is not significantly different for
elongated or normal-length Cw6 (t-test p.0.1) provides further
evidence that both normal-length and elongated Cw6 are similarly
able to bind KIR2DL1 at immune synapses.
Segregation of Cw6 by size at the immune synapse
We next tested whether Cw6 and Cw6-CD4 segregate or co-
localise within the IS. We expressed normal-length and/or
elongated Cw6 fused to different fluorescent proteins in 221 cells
and visualized by confocal microscopy their location at inhibitory
synapses with YTS-KIR2DL1 (Figure 5). Strikingly, elongated
Cw6-CD4-GFP, segregated from normal-length Cw6-mCherry
(Pearson coefficient r =20.2860.17 (SD), n= 10; Figure 5).
Interestingly, the longer Cw6 tended to accumulate at the
periphery of the IS (Figure S5). Importantly, normal-length
Cw6-GFP and Cw6-mCherry co-localised at the IS, confirming
that the type of the fluorescent tag itself did not affect segregation
(Pearson coefficient r = 0.7760.14, n = 6; Figure 5). Finally,
elongated Cw6-CD4-GFP co-localised with Cw6-CD4-mCherry
(r = 0.7160.22, n= 7). These results demonstrate that differences
in size are sufficient to drive segregation of proteins within the IS.
Matching activating and inhibitory receptor/ligand size is
important for signal integration
Our finding that size-compatibility may be required for
colocalisation raised the possibility that the elongation of HLA-
Cw6 abrogates its inhibitory effect on NK cell activation because it
prevents colocalisation of engaged KIR2DL1 with the engaged
activating receptor(s) within the IS. We tested this possibility by
varying the dimensions of both activating and inhibitory ligands
simultaneously. Specifically, we compared lysis by KIR2DL1-
expressing NKL cells of P815 cells expressing different combina-
tions of normal-length or elongated MICA and Cw6 at matching
Figure 2. Elongated MICA binds NKG2D. (A) Binding of NKG2D beads. P815 expressing normal-length or elongated MICA were incubated with
uncoated fluorescent beads, or beads coated with NKG2D-Fc or (control) MICA-Fc. Bead binding was analysed by flow cytometry and expressed as
percentage of cells forming conjugates to bead. The mean (normalized to the number of conjugates for NKG2D beads to P815 MICA) and SD of three
independent experiments are shown. (B) Conjugation of P815 and NKL cells. PKH67-labeled P815 cells expressing the indicated form of MICA were
incubated for 30 min with the equal number of PKH26-labeled NKL cells and analysed by flow cytometry. The percentage of the NKL cells forming
conjugates with P815 cells is shown. The data represents the mean and SD of three independent experiments. p = 0.04; 0.06; 0.02; 0.007 for P815 vs.
MICA; MICA-CD2; MICA-CD22; MICA-CD4 respectively (one-tailed t-test). (C) Clustering of MICA in NKL immune synapses. P815 cells expressing the
indicated length variant (or normal-length) of MICA-GFP were allowed to form contacts with NKG2D-expressing NKL cells for 10 min and imaged by
live-cell confocal microscopy. Clustering was quantified as fold-enrichment of GFP fluorescence intensity within the contact area versus outside the
contact area. Each point represents an individual cell/cell contact with the mean and SD shown. The scale bars represent 10 mm.
doi:10.1371/journal.pone.0015374.g002
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levels of expression (Figure 6A). As shown previously, expression of
normal-length MICA on P815 cells provoked killing by NKL cells
(Figure 6B). Simultaneous expression on these cells of normal-
length Cw6 was able to inhibit killing more effectively than
expression of elongated Cw6 (Figure 6B). We next examined the
effect of varying Cw6 length when MICA is elongated. Since
elongation of MICA abrogates NKL activation (see Figure 1C, E)
we augmented NKL activation by adding IL-2 and IL-12 to these
assays. Under these conditions elongated MICA elicited killing,
albeit more weakly that normal length MICA (Figure 6B). In
contrast to the results obtained with normal length MICA, in P815
cells expressing elongated MICA simultaneous expression on
normal length Cw6 did not inhibit killing, whereas expression of
elongated Cw6 was able to inhibit killing (Figure 6B). Thus
optimal inhibition by Cw6 of MICA-mediated killing was
observed when Cw6 and MICA where matched in size.
Similar results were obtained using IFN-c secretion as a readout
of NKL cell activation (Figure S6A). Simultaneous expression of
normal-length Cw6, but not elongated Cw6, was able to inhibit
IFN-c secretion induced by normal-length MICA (Figure S6A).
Indeed, elongated Cw6 actually augmented IFN-c secretion
induced by MICA (Figure S6A). Conversely, normal length Cw6
but not elongated Cw6 augmented IFN-c secretion induced by
elongated MICA (Figure S6A). These positive effects probably
arises from the greatly improved adhesion of NKL cells to P815
cells mediated by the KIR2DL1 interaction with normal-length or
elongated Cw6 (Figure S6B), and may be particularly evident here
as NKL and P815 cells are from different species and so lack
endogenous adhesion receptor/ligand pairs. Furthermore, the
secretion of cytokines is more dependent on the stability of the
intercellular contact than target cell killing [45].
Taken together, these results indicate that the ligands MICA
and Cw6 need to be matched in size for appropriate integration
of positive and negative signals from their respective receptors. A
plausible explanation for this is that the inhibitory KIRL2DL1-
Cw6 complex needs to span the same distance as the activating
NKG2D-MICA complex in order to colocalise with it. To
examine this directly we used confocal microscopy to determine
the distribution of normal-length and elongated forms of MICA-
GFP and Cw6-mCherry within IS between KIR2DL1-expressing
NKL and 221 cells (Figure 6C). Normal-length HLA-Cw6 co-
localised with normal-length MICA (Pearson’s correlation
coefficient, r = 0.6560.14 (SD), n = 12) whilst elongated MICA-
CD4 segregated from normal-length Cw6 (r =20.1660.33,
n = 11). Conversely elongated Cw6-CD4 co-localised with
elongated MICA-CD4 (r = 0.5160.19, n = 12) but not with
normal-length MICA (r =20.0760.33, n = 13). This indicates
that co-localization of activating and inhibitory receptors within
the IS is dependent on matching ligand/receptor complex
dimensions.
Figure 3. Elongation of HLA-Cw6 abrogates its inhibitory effect. (A) Normal-length and elongated forms of HLA-Cw6 were expressed on 221
cells at matched (high or low) levels. (B) 221 target cells expressing normal-length or elongated Cw6 were incubated with KIR2DL1-expressing YTS
effector cells for 5 h at the indicated E:T ratios. Lysis of 221 cells was assayed as in Figure 1B. (C) YTS-KIR2DL1 cells were stimulated with 221 cells
expressing no, low or high levels of the indicated form of Cw6 for 16 h. Supernatants were harvested and IFN-c secretion quantified by ELISA. Data in
B and C are representative results from four independent experiments. Error bars are SD of triplicate measurements.
doi:10.1371/journal.pone.0015374.g003
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Discussion
The ectodomains of leukocyte cell surface molecules vary
greatly in size [21,46]. Here, we set out to test for the first time
whether the size of ligands for activating and inhibitory NK cell
receptors influences NK cell responses. We first tested the
functional consequence of elongating the extracellular domain of
MICA by insertion of 2–4 domain spacers. While normal-length
MICA was sufficient to trigger activation of NKL or primary NK
cells, elongated forms of MICA were less effective, and the
functional response was inversely correlated with MICA length.
We showed that elongation did not abrogate NKG2D binding to
MICA but did abrogate early signaling, as measured by SLP-76
phosphorylation. Taken together these findings suggest that
elongation of MICA abrogates NKG2D triggering. The kinetic-
segregation model predicts that elongation of a receptor/ligand
complex would abrogate signaling because the increased inter-
membrane distance leads to less effective segregation of the
engaged receptor from tyrosine phosphatases with large ectodo-
mains. This is consistent with very recent data showing that
elongation of mouse ligands for NKG2D also abrogated their
efficacy in triggering NK cell activation [47]. Thus, the results
presented here, showing that elongation of MICA abrogates
NKG2D triggering, is consistent with NKG2D signaling involving
the kinetic-segregation mechanism.
There are many activating receptors other than NKG2D
expressed on NK cells, with 16 identified in humans [2]. While
they vary in structure they have in common the fact that they are
small and, where identified, their cell-surface ligands are also small
[2]. Also, with the probable exception of DNAM-1 (CD226), they
all signal by tyrosine phosphorylation of their cytoplasmic domains
or the cytoplasmic domains of associated signaling subunits such as
DAP10, DAP12 or CD3f, and this phosphorylation is thought to
be mediated Src-like tyrosine kinases [2]. Thus, taken together
with our finding that activation through NKG2D is inhibited by
elongation its ligand, kinetic-segregation might be important for
signaling by many if not all activating NK receptors.
We next investigated whether recognition by an inhibitory NK
cell receptor was also dependent on ligand size. To do this we
expressed a single-chain trimer form of HLA-Cw6 (Cw6)
incorporating a peptide predicted to be compatible with
KIR2DL1 binding. We used the single chain trimer to rule out
any effect of elongation on peptide loading, as this could indirectly
affect KIR recognition [48,49]. Expression of normal-length Cw6
on 721.221 cells inhibited killing by KIR2DL1-expressing YTS
cells. Elongation of Cw6, while not affecting binding to KIR2DL1,
reduced its ability to inhibit NK cell-mediated lysis, with inhibition
broadly inversely correlated with Cw6 length. It has also recently
been reported that elongation of a mouse MHC class I molecule
on target cells abrogates its inhibitory effect on mouse NK cell
killing [47]. The inhibitory effect of KIR2DL1 requires phos-
phorylation of cytoplasmic tyrosine residues. One possible
mechanism by which elongation of Cw6 abrogates KIR2DL1
function is that it inhibits signaling. Given the small size of the
Figure 4. Elongated HLA-Cw6 binds KIR2DL1. (A) Binding of KIR2DL1 beads. 221 cells expressing the indicated form of Cw6 were incubated
with fluorescent beads coated with KIR2DL1-CD4d34 or CD4d34. Bead binding was analysed by flow cytometry and expressed as percentage of cells
forming conjugates to bead. A representative of two experiments is shown, the error bars represent the SD of triplicates. (B) P815 cells expressing
normal-length or elongated Cw6 were allowed to form conjugates with equal numbers of KIR2DL1-expressing NKL cells for 30 min. The number of
conjugates was determined as in Figure 2B. (1-tailed t-test: p = 0.025 for P815-Cw6 vs. P815, p = 0.037 for P815-Cw6-CD4 vs. P815 (C) Clustering of
Cw6 and KIR2DL1 in YTS-221 immune synapses. 221 cells expressing the indicated Cw6-mCherry were allowed to form contacts with KIR2DL1-GFP -
expressing YTS cells for 30 min and imaged live by confocal microscopy. Clustering was quantified as fold-enrichment of GFP brightness within the
contact area versus outside the contact area. Each point represents an individual cell/cell contact with the mean and SD shown as lines, p = 0.11 (2-
tailed t-test). The scale bar represents 10 mm.
doi:10.1371/journal.pone.0015374.g004
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KIR2DL1-Cw6 complex, and the fact that signaling through
KIR2DL1 is initiated by tyrosine phosphorylation of its cytoplas-
mic domain ITIM motif by Src kinases, it is plausible that
KIR2DL1 signals through the kinetic-segregation mechanism. An
alternative possibility is that KIR2DL1 is phosphorylated by Src
kinases associated with other nearby small receptors, and that
elongation of Cw6 inhibits signalling by preventing colocalization
of KIR2DL1 with these receptors. Further studies are required to
distinguish between these mechanisms.
Our finding that normal-length and elongated Cw6 spontane-
ously segregated at the IS shows that size differences alone are
sufficient to drive segregation of receptor/ligand complexes in the
IS. It has previously been shown that HLA-Cw6 segregated from
regions enriched in ICAM-1 in a manner largely independent of
cytoskeletal or ATP-dependent processes [17,37,50]. In addition,
proteins were seen to segregate at synapses when expressed in
insect cells thought not to express other ligands for human NK
cells [51]. Our finding that differences in the molecular size alone
are sufficient to drive segregation at the NK IS provides an
explanation for these observations.
Inhibitory NK receptors such as KIR2DL1 abrogate NK
cell activation by recruiting to the plasma membrane tyrosine
phosphatases such as SHP-1 and SHP-2 and the inositol lipid
phosphatases SHIP, where they directly oppose or reverse
phosphorylation triggered by engagement of activating receptors
[2]. This suggests that for inhibitory receptors to be effective they
would need to co-localise with engaged activating receptors in the IS.
This is supported by a recent study of NK activation on surfaces
presenting micropatterned NK receptor ligands [52]. Our observa-
tion that differences in size alone result in segregation suggests that
inhibitory receptor-ligand complexes would need to be similar in size
to activating receptor-ligand complexes to colocalise with them and
inhibit the activating signals. To test this hypothesis, we used cells
expressing both normal-length or elongated Cw6 and normal-length
or elongated MICA, in all 4 possible combinations. Our results
confirmed that matched sizes of MICA and Cw6 proteins were
important for co-localization within the IS and for signal integration;
Cw6 and MICA colocalised best when they were similar in size.
Similarly, normal sized Cw6 could only inhibit activation by normal-
lengthMICA, while elongated Cw6 could only inhibit stimulation by
elongatedMICA. Thus, optimal signal integration between NKG2D
and KIR2DL1 requires that NKG2D/MICA and KIR2DL1/Cw6
complexes are matched in size, probably because this is required for
their colocalisation within the IS.
Figure 5. Size differences drive segregation of different length variants of HLA-Cw6 within immune synapses. 221 cells double-
transfected with normal-length or CD4-elongated forms of Cw6 fused to either GFP (green) or mCherry (red) were incubated for 30 min with
KIR2DL1-expressing YTS transfectants and conjugates were imaged by live-cell confocal microscopy. En-face views of the synapse were reconstructed
and the Pearson correlation coefficient (r) for GFP and mCherry fluorescence were determined. Mean 6 SD of the total number of conjugates is
shown. The scale bar represents 10 mm.
doi:10.1371/journal.pone.0015374.g005
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Our demonstration of the functional importance of matching
dimensions of NKG2D/MICA and KIR2DL1/Cw6 raises the
question as to whether this is required for signal integration
between other activating and inhibitory NK receptors. In support
of this the available structural information suggests that inhibitory
receptor/ligand complexes all span similar dimensions (10–
15 nm), despite significant variation in inhibitory receptor
structure and length. For example although the LIR-1 (ILT-2)
receptor has 4 Ig domains compared with the 2 Ig domains of
most KIR molecules, it binds the membrane-proximal rather than
the membrane-distal portion of MHC class I molecules [53], so
that LIR-1/MHC class I and KIR2D/MHC class I complexes
span similar distances. Furthermore, whereas KIR3D receptors
have one more Ig domain than KIR2D receptors the two
membrane-proximal Ig domains of both receptors are involved in
binding [54], and so KIR3D-MHC class I and KIR2D-MHC
class I complexes span a similar size. The similarity in the
dimensions of activating and inhibitory NK receptor-ligand
complexes, despite variation in primary structure and mode of
binding, strongly suggests that this is of functional importance.
In conclusion, we have shown that elongation of the NKG2D
ligand MICA abrogates NKG2D signaling, consistent with a role
for the kinetic-segregation mechanism in signal transduction
through NK receptors. We have also shown that the dimensions
of complexes KIR2DL1-HLA-Cw6 and NKG2D-MICA need to
be matched for optimal signal integration and colocalization in the
NK cell IS. Our results suggest that size-dependent organisation of
molecules within immune synapses is an important general
principle for immune cell recognition.
Materials and Methods
Cell lines
The HLA-A/B/C negative human B-cell line 721.221 [55]
[subsequently abbreviated as 221], the murine mastocytoma line
P815 (ATCC, catalogue number TIB-64), and the EBV-immortal-
ized human NK cell line YTS [42] were cultured in DMEM
supplemented with 10% heat-inactivated FCS, 100 mg/ml strepto-
mycin, 100 U/ml penicillin (all Invitrogen, Paisley, UK). The
human NK cell leukemia line NKL [56], was cultured in RPMI-
1640 supplemented with 10% heat-inactivated FCS, 100 mg/ml
streptomycin, 100 U/ml penicillin, L-glutamine, b-mercaptoetha-
nol, non-essential amino acids (all Invitrogen) and 100 U/ml IL-2
(Roche, Welwyn, UK). Primary human NK cells were isolated from
healthy donor blood by negative magnetic selection (Miltenyi,
Bergisch Gladbach, Germany) and cultured as described previously
Figure 6. The size of Cw6 and MICA influences their localization within the synapse and the integration of their receptor signals. (A)
A panel of P815 transfectants were produced expressing matching levels of normal-length or elongated MICA and Cw6. (B) NKL cells expressing the
inhibitory receptor KIR2DL1 were mixed with P815 cells (E:T 20:1) and cytotoxic activity determined as in Figure 1B. To augment cytotoxicity triggered
by elongated MICA, IL-2 (100 U/ml) and IL-12 (10 ng/ml) were added exogenously. Data shown is representative of three independent experiments
(mean 6 SD of triplicates). (C, D) Organization of normal-length and elongated Cw6 and MICA in immune synapses. 221 cells expressing normal-
length or elongated Cw6-mCherry (red) and MICA-GFP (green) were incubated with KIR2DL1-expressing NKL cells for 30 min before imaging by live-
cell confocal microscopy. Scale bar represents 10 mm. From acquired image stacks, en-face views of the contact regions were reconstructed and the
Pearson correlation coefficients (r) between GFP and mCherry fluorescence were determined. Data points represent individual synapses and the
mean and SD are shown (p= 4.161027 for MICA plus Cw6 vs. MICA plus Cw6-CD4; 1.361027 for MICA plus Cw6 vs. MICA-CD4 plus Cw6; 0.05 for MICA
plus HLA vs. MICA-CD4 plus Cw6-CD4 (2-tailed t-test).
doi:10.1371/journal.pone.0015374.g006
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[57]. Primary NK cells were stimulated in 200 U/ml IL-2 for 4–5
days before the functional assays unless stated otherwise. Ethical
approval was obtained from the Riverside Health Centre Ethics
Committee (London, UK) and written informed consent was
obtained from donors before obtaining and using their cells.
Fusion protein constructs
Constructs encoding MICA and a single chain trimer version of
HLA-Cw6 (hereafter termed Cw6) were generated in pcDNA3.1+
using a similar approach to that previously described [30,31]. The
junctions between MICA or Cw6 and C-terminal GFP/mCherry
were (single letter amino acid code) EGAADPPVATMVSKG and
ACKAGGRSMVSKG, respectively (junctional sequences under-
lined). The sequences preceding the additional junctional
sequences are the C-termini of MICA and Cw6, and the sequence
following them are the identical N-termini of GFP or mCherry. To
facilitate the insertion of protein spacers, in-frame BamHI sites
were introduced immediately after Thr292 and Trp288 in the
stalk regions of MICA and Cw6, respectively. This required the
mutation to Asp of His293 and Glu289 in MICA and Cw6,
respectively. Fragments encoding the ectodomains of human CD2
and CD4, and the three N-terminal Ig domains of the mouse
CD22 ectodomain were generated and inserted into these BamHI
sites, as previously described [30,31].
To facilitate the transfer of these constructs into the lentiviral
vector pHR-SIN-BX-IRES-Em, an MluI site was introduced 6
base pairs upstream of the Not I site. The fragments encoding
normal-length and elongated MICA and Cw6 with C-terminal
tags of GFP or mCherry were amplified using forward and reverse
primers that added Xho I and Mlu I sites, respectively, and then
inserted into the XhoI/MluI sites of pHR-SIN-BX-IRES-Em.
NKL-KIR2DL1-CFP transfectants was generated as follows: First,
EGFP in the pEGFPN1 vector was exchanged with mCFP as a
BamHI/BsrGI fragment, resulting in pMCFPN1. Then,
KIR2DL1 was subcloned into pMCFPN1 from pcDNA3.1-
KIR2DL1-CGFP (a kind gift from M. Purbhoo) using the
HindIII/BamHI restriction sites. KIR2DL1-CFP was then
subcloned from pMCFPN1-KIR2DL1 into the pIB2 vector
transferring a blasticidin resistance (a kind gift from M. Purbhoo).
Expression of cell surface proteins
Normal-length and elongated versions of Cw6 and MICA fused
to GFP or mCherry [58] were expressed in target cells using
lentiviral transduction. For this, 70–80% confluent 293T cells in a
175 cm2 flask were transfected with 14 mg expression vector pHR-
SIN-BX-IRES-Em; 21 mg Vpack 11 mg VSVG (Stratagene, La
Jolla, CA, USA), in 10 mM polyethylenimine. Supernatants
cultured from 293T transfectants were taken 2 days later and
concentrated 20 times. 26106 221 or P815 cells were transduced
with 1 ml lentivirus-containing supernatant for 4 hours, then
cultured in complete medium for another 2 days. NKL were
transduced by retrovirus produced by transfection of the Phoenix
packaging cell line and selected with blasticidin. Transduced cells
were sorted by flow cytometry (FACS DiVa/Aria II, BD/DAKO)
based on fusion protein fluorescence and/or surface antigen
staining. Fusion proteins were detected using anti-MICA staining
(R&D, Abingdon, UK), followed by anti-mouse Alexa633, or Cy5-
labeled anti-HLA (clone W6/32, ATCC). Fc receptors of P815
cells were pre-blocked by adding 2 mg/ml anti-CD16/CD32 (Fc
block, BD, Oxford, UK) prior to antibody staining.
Functional and binding assays
For NK cell activation assays, sorted transfectants of matching
expression levels of the different length MICA/HLA were
selected. NK cell cytotoxicity was determined using standard
[35S]-Met radioactive release assays for 5 h.
In order to validate the ability of the MICA-fusion proteins to
engage NKG2D, transfected cells were analyzed using conjugation
assays with NKG2D beads. For this, streptavidin beads (Bangs
Laboratories, Fishers, IN, USA) were coated with biotinylated
anti-human Fc (Sigma, 5 mg/ml in PBS +0.1% BSA) at 4uC for
1 h under agitation. After washing three times with PBS, beads
were coated with 10 mg/ml NKG2D-Fc fusion protein, or 10 mg/
ml MICA-Fc fusion protein as a negative control (both R&D),
followed by labelling with additionally anti-mouse-Alexa 633
(Molecular Probes). Following three washing steps with PBS, the
beads were mixed with the target cells in a 96-well plate to a final
density of 106 cells each, briefly spun down and allowed to form
conjugates for 1 h before fixing with ice-cold paraformaldehyde
(total concentration 1%), followed by flow cytometry.
A similar bead binding assay was used to check the ability of the
normal-length and elongated Cw6-fusion proteins to bind
KIR2DL1. KIR2DL1 was expressed as a fusion protein
KIR2DL1-CD4d34 comprising the entire KIR2DL1 ectodomain
followed by rat CD4 domains 3 and 4 and the BirA biotinylation
tag added at the C-terminus [59]. The sequence at the junction
between KIR2DL1 and the CD4 was GNPRHLHGSTSITAYK
(KIR2DL1 underlined). KIR2DL1-CD4d34 and a control protein
CD4d34 lacking the KIR2DL1 portion were expressed, biotiny-
lated, and coated onto avidin fluorescent beads (Spherotech) as
previously described [59]. KIR2DL1-CD4d34 or CD4d34-coated
fluorescent beads (15 mL) were incubated with 0.5 * 106 221 cells
expressing various Cw6 proteins at 4uC for 2 hours and bead
binding to 221 cells was measured by flow cytometry. For
antibody-mediated blocking of bead binding, antibodies against
MICA (R&D, stock concentration 0.5 mg/ml), or KIR2DL1
(HP3E4 hybridoma supernatant) were added to the cell/bead mix
diluted as indicated.
Cell conjugation assays were performed based on previous
protocols [60]. For the analysis of NKL conjugation with P815
transfectants, NK cells were stained with the red fluorescent dye
PKH26 (2 mM), target cells with the green fluorescent dye PKH67
(2 mM) (both Sigma-Aldrich, Dorset, UK). After washing, 50 mL of
2 * 106 cells/ml each of NK cell and target cell were mixed in a 96
well V-bottom plate, briefly spun down, and incubated for the times
indicated. Conjugation was stopped by adding ice-cold parafor-
maldehyde to a final concentration of 1%, and conjugates were
analysed by flow cytometry. The percentage of PKH26-labeled NK
cells forming conjugates with PKH67-labeled target cells was
determined as the number of double-positive events [100*(NK cells
in conjugate)/(total number of NK cells)] (FloJo software).
IFN-c expression and secretion were quantified by intracellar
cytokine staining and ELISA, respectively, using standard
protocols (antibodies from BD bioscience). The assay for
degranulation was performed as described previously [61]: 106
target cells/ml were cocultured with a different ratio of effector
cells in a 48-well plate. Control wells contained either NK cells
alone or NK cells stimulated with PMA (2.5 mg/ml) and
ionomycin (0.5 mg/ml). PE-conjugated anti-CD107a mAb (Santa
Cruz Biotechnology) was added and incubated for 1 h at 37uC.
The exocytosis inhibitor monensin was added to a final
concentration of 6 mg/ml and the incubation continued for a
further 4 hours. Cells were washed 2 times with PBS, and in some
experiments NK cells were stained for CD2, before analysis by
flow cytometry (FACSCalibur).
For the analysis of SLP-76 phosphorylation by Western
Blotting, 106 NKL cells were stimulated by 106 control or
MICA-transduced P815 cells for 2 minutes in a 37uC water bath.
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Pelleted cells were sonicated for 5 s, and the samples then analysed
using SDS-PAGE gel and Western Blot. Membranes were stained
with Ab against SLP-76 phospho-tyrosine 113 (Abcam, Cam-
bridge, UK) (1:1000), followed by peroxidase-conjugated second-
ary antibody (1:4000), and visualized by X-ray film.
Microscopy and Image Analysis
Protein localization at NK/target cell synapses was determined
by imaging live cells at 37uC/5% CO2 in 8-well glass bottom
chamberslides (Labtek) using an inverted laser-scanning confocal
fluorescence microscope (SP5, Leica) equipped with a 63x 1.2 NA
water immersion objective, and a resonance scanner. Laser
wavelengths of 488 and 591 nm were used for the excitation of
GFP and mCherry, respectively. En-face views of the intercellular
contact were rendered from multiple optical slices (Volocity,
Improvision, Waltham, MA, USA). Quantification of fluorescence
at the intercellular contact, and the determination of Pearson
correlation coefficient r for the GFP and mCherry channel at the
IS were performed using ImageJ (National Institute of Health).
Supporting Information
Figure S1 MICA elongation affects NK cell activation.
(A) MICA elongation affects intracellular IFN-c. NKL cells were
incubated for 1 h with equal numbers of P815 cells expressing the
indicated length variant (or normal-length) MICA before adding
Brefeldin A (5 mg/ml) and incubating for a further 4 h. Cells were
then fixed and permeabilized, stained with PE-conjugated IFN-c
mAb, and analysed by flow cytometry. The percentage of IFN-c+
NK cells is shown. (B) MICA elongation affects degranulation.
NKL cells were incubated for 5 h in the presence of monensin
with equal numbers of P815 cells expressing the indicated MICA.
Degranulation was measured by CD107a antibody staining. The
percentage of CD107a-positive NK cells is shown. These data
represent the mean and SD of two independent experiments.
Found at: doi:10.1371/journal.pone.0015374.s001 (TIF)
Figure S2 NKG2D-bead binding to MICA-expressing
P815 cells in the presence of blocking antibody. Fluorescent
streptavidin beads (Spherotech) were functionalized with NKG2D
as described for Figure 2A. The indicated P815 cells were pre-
treated with a MICA blocking Ab (R&D) at the indicated dilution
(stock solution 50 mg/ml) in PBS +5% mouse serum for 30 min.
NKG2D-coated beads were then incubated with these cells for 1 h
at room temperature the number of bead-conjugated cells
determined by flow cytometry. The data are a representative of 2
independent experiments.
Found at: doi:10.1371/journal.pone.0015374.s002 (TIF)
Figure S3 Cw6 elongation abrogates inhibition of NK
cell activation. YTS-KIR2DL1 cells were co-incubated with
221 cells expressing the indicated variant of Cw6 and intracellular
IFN-c was measured as described in Figure S1A. Data represent
the mean and range of two independent experiments.
Found at: doi:10.1371/journal.pone.0015374.s003 (TIF)
Figure S4 KIR2DL1-bead binding to Cw6-expressing
221 cells in the presence of blocking antibody. Fluorescent
streptavidin beads were functionalized with KIR2DL1-Fc (a kind
gift from Peter Parham, Stanford), as described for Figure 2A, and
then pre-incubated with the indicated dilution of HP3E4 (stock
solution 1:10 hybridoma supernatant). These KIR2DL1-coated
beads were then incubated in PBS +5% mouse serum for 1 h at
room temperature with the indicated 221 cells, and the number of
bead-conjugated cells determined by flow cytometry. The data is
representative of 2 independent experiments.
Found at: doi:10.1371/journal.pone.0015374.s004 (TIF)
Figure S5 Elongation of Cw6 increases clustering at the
synapse periphery. 221 cells expressing GFP-tagged versions of
HLA-Cw6 heavy chain (i.e. wild type Cw6) or normal-length
(Cw6) or elongated (Cw6-CD4) single chain trimer versions of
HLA-Cw6 were incubated with YTS-KIR2DL1 cells for 30 min
and conjugates imaged by confocal microscopy. The relative
location of the GFP clusters was determined by dividing the
distance between the cluster centre and synapse centre by the
diameter of the synapse, plotted at the y-axis. Each point
represents an individual cell/cell contact with the mean and SD
shown as lines, * denotes p,10-5.
Found at: doi:10.1371/journal.pone.0015374.s005 (TIF)
Figure S6 The size of Cw6 and MICA influences the
integration of their receptor signals. (A) NKL cells
expressing the inhibitory receptor KIR2DL1 were incubated with
the indicated P815 cells for 16 h before supernatants were
harvested and IFN-c measured. To augment IFN-c secretion
triggered by elongated MICA, IL-2 (100 U/ml) and IL-12 (10 ng/
ml) were added exogenously. Data shown is representative of three
independent experiments (mean6 SD of triplicates). (B) P815 cells
expressing the indicated molecules were incubated with equal
numbers of KIR2DL1-expressing NKL cells for 30 min. The
number of conjugates was determined as in Figure 2B.
Found at: doi:10.1371/journal.pone.0015374.s006 (TIF)
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